These results could be related to a higher prevalence of NAFLD in subjects with decreased ZAG gene expression levels, although it is important to bear in mind that the presence of this disease was not specifically assessed in the study, and normal values of GGT and transaminases do not exclude the presence of NAFLD. Here, AZGP1 is linked to metabolic dysfunction-associated steatotic liver disease.